• Subscribe
  • Webinars
  • White Papers
  • Buyer's Guide
  • PhotonicsNXT
  • Get Published!
    • Recent Quotes
    My Watchlist
    Indicators
    BioOptics Stock Watch
    Markets
    Stocks
    ETFs
    Tools
    Overview
    News
    Currencies
    International
    Treasuries

    Quest Diagnostics (NY: DGX )

    153.10 +1.58 (+1.04%)
    Official Closing Price Updated: 7:00 PM EST, Dec 20, 2024 Add to My Watchlist
    Quote
    Overview Detailed Quote Charting Historical Prices
    News
    All News News Headlines Press Releases
    Research
    Quarterly Reports Insider Filings Other Filings

    Price and Volume

    Detailed Quote
    Volume 1,400,131
    Open 151.68
    Bid (Size) 150.13 (1)
    Ask (Size) 156.36 (1)
    Prev. Close 151.52
    Today's Range 151.68 - 154.10
    52wk Range 123.04 - 165.32
    Shares Outstanding 122,180,759
    Dividend Yield 1.96%
    Chart for (: )
    Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

    Top News

    More News
    Quest Diagnostics (NYSE: DGX) And Mainz Biomed (NASDAQ: MYNZ) Team Up To Commercialize ColoAlert Early Cancer Detection Screening In The U.S.
    Quest Diagnostics (NYSE: DGX) And Mainz Biomed (NASDAQ: MYNZ) Team Up To Commercialize ColoAlert Early Cancer Detection Screening In The U.S. 
    Via News Direct
    Exposures Product Safety
    Your Healthcare Costs are Soaring! US Spending Reached $5 Trillion In 2023 with Major Increase in Obesity and Diabetes Drugs, Hospital Services
    U.S. healthcare spending grew 7.5% to $4.9 trillion in 2023, with hospital care and prescription drugs driving costs. Private insurance accounted for 30% of total spending. 
    Via Benzinga

    Performance

    YTD
    +8.72%
    +8.72%
    1 Month
    -6.58%
    -6.58%
    3 Month
    -0.57%
    -0.57%
    6 Month
    +9.18%
    +9.18%
    1 Year
    +11.96%
    +11.96%

    More News

    Read More
    Mainz Biomed Forms Agreement with Quest Diagnostics to Provide Clinical Trials Laboratory Services for Colorectal Cancer Screening Test
    From Mainz BioMed NV
    Via GlobeNewswire
    The Analyst Landscape: 8 Takes On Quest Diagnostics
    Via Benzinga
    (DGX) - Analyzing Quest Diagnostics's Short Interest
    Via Benzinga
    Tesla To Rally More Than 11%? Here Are 10 Top Analyst Forecasts For Tuesday
    Via Benzinga
    This Tesla Analyst Turns Bullish; Here Are Top 5 Upgrades For Tuesday
    Via Benzinga
    Guardant Health Stock Sees RS Rating Jump To 83
    Via Investor's Business Daily
    Navigating Earnings Season: Weather Any Storm
    Via Talk Markets
    How Is The Market Feeling About Quest Diagnostics?
    Via Benzinga
    What Analysts Are Saying About Quest Diagnostics Stock
    Via Benzinga
    Cracking The Code: Understanding Analyst Reviews For Quest Diagnostics
    Via Benzinga
    Earnings Preview: Quest Diagnostics
    Via Benzinga
    Looking Into Quest Diagnostics's Recent Short Interest
    Via Benzinga
    Donald Trump's Second Term Could Reshape US Healthcare System, With Major Impacts on Affordable Care Act And Medicare
    Via Benzinga
    Topics Government
    Exposures Political
    Laboratory Corp Q3 Earnings Beat Street View, Investors Overlook Hurricane Helene Impact
    Via Benzinga
    Topics Earnings
    Exposures Financial
    This Snap Analyst Turns Bullish; Here Are Top 5 Upgrades For Wednesday
    Via Benzinga
    Quest Diagnostics Posts Upbeat Results, Joins GM, Philip Morris And Other Big Stocks Moving Higher On Tuesday
    Via Benzinga
    Decoding 7 Analyst Evaluations For Quest Diagnostics
    Via Benzinga
    What Analysts Are Saying About Quest Diagnostics Stock
    Via Benzinga
    Quest Diagnostics CEO Touts 'New Customer Wins' In Q3, Expects Earnings Growth In 2025
    Via Benzinga
    Uber To Rally Over 33%? Here Are 10 Top Analyst Forecasts For Monday
    Via Benzinga
    Diagnostic Giants Labcorp, Roche To Ramp Up Testing Capacity Amid Global Concerns Over New Mpox Strain
    Via Benzinga
    8 Health Care Stocks With Whale Alerts In Today's Session
    Via Benzinga
    LabCorp's Stock Soars After Q2 Performance, Analyst Highlights Strong Position In Healthcare Sector
    Via Benzinga
    Stock Quote API & Stock News API supplied by www.cloudquote.io
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the following
    Privacy Policy and Terms and Conditions.